Drawing for QUESTINE

USPTO serial 77896014

QUESTINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLANDU, FLORENTINA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QUESTINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Davis

DAVID J. DAVIS BAKER & MCKENZIE LLP300 E. Randolph StreetSuite 5000CHICAGO, IL 60601-6225

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic medical test employing diagnostic assays or reagent preparations in the form of fluids, for non-invasive collection of bodily specimens, for use in testing for various diseases and medical conditions in the nature of infections, infectious diseases and conditions, genetic diseases and conditions, malignant diseases and conditions, inflammatory diseases and conditions, neurological and nervous systems diseases and conditions, blood disorders, blood diseases, cardiovascular diseases and conditions, pulmonary diseases and conditions, metabolic diseases and conditions, urological diseases and conditions, fungal diseases and conditions, liver diseases and conditions, autoimmune and immunological diseases and conditions, adrenal disease, endocrine, exocrine and lymphatic diseases and conditions, skin diseases and conditions, eye diseases and conditions, ear, nose and throat diseases and conditions, intestinal diseases and conditions, gynecological diseases and conditions, pre-natal and reproductive disorders, hormonal disorders, tumors, cancers, bacteria, bacterial infections, viruses, viral infections, abused drugs or dietary deficiencies; medical diagnostic reagentsACTIVE—
042provision of medical diagnostic laboratory testing services; Scientific consultation services relating to scientific investigations for medical, research and clinical trial purposesACTIVE—
044Provision of medical diagnostic laboratory testing services; Medical and testing information services, namely, providing information regarding diagnostic testing results, testing procedures, disease conditions and disease prevention; medical and scientific consultation servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 15, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 15, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 12, 2012EX3GSOU EXTENSION 3 GRANTED—
Dec 11, 2012EXT3SOU EXTENSION 3 FILED—
Dec 11, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2012EX2GSOU EXTENSION 2 GRANTED—
Jun 21, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 30, 2012EXT2SOU EXTENSION 2 FILED—
May 30, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 30, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Sep 28, 2011EX1GSOU EXTENSION 1 GRANTED—
Sep 28, 2011EXT1SOU EXTENSION 1 FILED—
Sep 28, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 14, 2011NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 19, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2011NPUBNOTICE OF PUBLICATION—
Mar 17, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 16, 2011ALIEASSIGNED TO LIE—
Feb 28, 2011CNEAEXAMINERS AMENDMENT MAILED—
Feb 28, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 31, 2010CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 30, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 28, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 28, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2010DOCKASSIGNED TO EXAMINER—
Dec 23, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance